Sheree Nwanegwo
Family Medicine · Myrtle Beach, SCNPI 1487610382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 185 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $918 and has fallen 78.8% since, to $195 in 2025.
Across 185 payments — averaging $16.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$562
- Johnson & Johnson$452
- Novo Nordisk$436
- Amgen$237
- AbbVie$225
- Amarin Pharma, Inc.$138
- plus $959 from 19 others
What the payments were for
- Food & beverage$2,994100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $562 |
| Johnson & Johnson | 33 | $452 |
| Novo Nordisk | 18 | $436 |
| Amgen(2 entities) | 15 | $237 |
| AbbVie(2 entities) | 16 | $225 |
| Amarin Pharma, Inc. | 8 | $138 |
| Lilly USA, LLC | 5 | $125 |
| Sanofi-aventis U.S. LLC | 8 | $118 |
| Pfizer | 8 | $115 |
| Radius Health, Inc. | 6 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $104 |
| Boehringer Ingelheim | 4 | $70 |
| GSK | 1 | $67 |
| IBSA Pharma Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Merck | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Gilead | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Aytu Biopharma, Inc. | 1 | $13 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$3,009 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Myrtle Beach
- Stephen BruntonWinnsboro$1.3M
- Richard WilkesMt Pleasant$216K
- Andrew MartinColumbia$205K
- Ada StewartColumbia$186K
- Jeffrey BroderNorth Augusta$140K
- Terry NagelColumbia$112K
- Katherine JohnsonGreenwood$80K
- Scott SmithMount Pleasant$68K
- Jennifer StolinSummerville$59K
- Nicholas PenningsNorth Myrtle Beach$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.